Shares of Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12-month price […]